Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Erika M Lewis"'
Autor:
Leland S. Hu, Fulvio D’Angelo, Taylor M. Weiskittel, Francesca P. Caruso, Shannon P. Fortin Ensign, Mylan R. Blomquist, Matthew J. Flick, Lujia Wang, Christopher P. Sereduk, Kevin Meng-Lin, Gustavo De Leon, Ashley Nespodzany, Javier C. Urcuyo, Ashlyn C Gonzales, Lee Curtin, Erika M. Lewis, Kyle W. Singleton, Timothy Dondlinger, Aliya Anil, Natenael B. Semmineh, Teresa Noviello, Reyna A. Patel, Panwen Wang, Junwen Wang, Jennifer M. Eschbacher, Andrea Hawkins-Daarud, Pamela R. Jackson, Itamar S. Grunfeld, Christian Elrod, Gina L. Mazza, Sam C. McGee, Lisa Paulson, Kamala Clark-Swanson, Yvette Lassiter-Morris, Kris A. Smith, Peter Nakaji, Bernard R. Bendok, Richard S. Zimmerman, Chandan Krishna, Devi P. Patra, Naresh P. Patel, Mark Lyons, Matthew Neal, Kliment Donev, Maciej M. Mrugala, Alyx B. Porter, Scott C. Beeman, Todd R. Jensen, Kathleen M. Schmainda, Yuxiang Zhou, Leslie C. Baxter, Christopher L. Plaisier, Jing Li, Hu Li, Anna Lasorella, C. Chad Quarles, Kristin R. Swanson, Michele Ceccarelli, Antonio Iavarone, Nhan L. Tran
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-20 (2023)
Abstract Sampling restrictions have hindered the comprehensive study of invasive non-enhancing (NE) high-grade glioma (HGG) cell populations driving tumor progression. Here, we present an integrated multi-omic analysis of spatially matched molecular
Externí odkaz:
https://doaj.org/article/a2809ec273b7446289807a553cea6a7f
Autor:
Costanza Lo Cascio, James B. McNamara, Ernesto L. Melendez, Erika M. Lewis, Matthew E. Dufault, Nader Sanai, Christopher L. Plaisier, Shwetal Mehta
Publikováno v:
JCI Insight, Vol 6, Iss 17 (2021)
Glioblastoma (GBM) is characterized by an aberrant yet druggable epigenetic landscape. One major family of epigenetic regulators, the histone deacetylases (HDACs), are considered promising therapeutic targets for GBM due to their repressive influence
Externí odkaz:
https://doaj.org/article/0c28bf317c584da09eb9a6ee5bd8d523
Autor:
Shawn S Striker, Sierra F Wilferd, Erika M Lewis, Samantha A O’Connor, Christopher L Plaisier
SummarySomatic mutations occur as random genetic changes in genes through protein-affecting mutations (PAMs), gene fusions, or copy number alterations (CNAs). Mutations of different types can have a similar phenotypic effect (i.e., allelic heterogene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4ff98d34b304748135265f94da00d79
https://doi.org/10.1101/2022.07.22.501139
https://doi.org/10.1101/2022.07.22.501139
Autor:
Shawn S. Striker, Sierra F. Wilferd, Erika M. Lewis, Samantha A. O'Connor, Christopher L. Plaisier
Publikováno v:
Cell Reports Methods. 3:100442
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a76d14a8279de5015c9bebd7ffb917b8
https://doi.org/10.1016/j.crmeth.2023.100442
https://doi.org/10.1016/j.crmeth.2023.100442
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::539dbc8a55dbd5921644fbb2aa2bc51f
https://doi.org/10.2139/ssrn.4186252
https://doi.org/10.2139/ssrn.4186252
Autor:
James McNamara, Ernesto Luna Melendez, Nader Sanai, Matthew E. Dufault, Shwetal Mehta, Erika M. Lewis, Costanza Lo Cascio, Christopher L. Plaisier
Publikováno v:
JCI Insight
Glioblastoma (GBM) is characterized by an aberrant yet druggable epigenetic landscape. One major family of epigenetic regulators, the histone deacetylases (HDACs), are considered promising therapeutic targets for GBM due to their repressive influence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e03ad53dd9122d50bdd858731dbf2bd0
https://doi.org/10.1172/jci.insight.149232
https://doi.org/10.1172/jci.insight.149232
Autor:
Shwetal Mehta, Erika M. Lewis, Ernesto Luna Melendez, James McNamara, Nader Sanai, Costanza Lo Cascio, Christopher L. Plaisier, Matthew E. Dufault
Publikováno v:
Neuro-Oncology. 23:vi25-vi25
Glioblastoma (GBM) is characterized by an aberrant yet druggable epigenetic landscape. One major family of epigenetic regulators, the Histone Deacetylases (HDACs), are considered promising therapeutic targets for GBM due to their repressive influence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2eac7c678dbadbf84504653eaa40480c
https://doi.org/10.1093/neuonc/noab196.093
https://doi.org/10.1093/neuonc/noab196.093